Skip To Main Content
Manas Mishra on Muck Rack

Manas Mishra

Verified
Bangalore, India
As seen in: Citeline, MSN, MSN Australia, MSN Canada, MSN Money Canada, MSN Singapore, MSN UK, O Globo, UOL, Yahoo Life, Business Insider and
@Reuters. Follow for healthcare/business related news and my obscure interests on your feed. Opinions are mine, and not those of my employer.

Get in touch with Manas

Contact Manas, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Sangamo’s Bankruptcy Sale Splits Gene Therapy Assets Between Lilly, PTC

|
By Manas Mishra Verified
| Scrip Verified
A distressed auction handed PTC Therapeutics a Fabry therapy months from filing and Eli Lilly several gene-editing and delivery platforms. The bankruptcy of gene-therapy developer Sangamo Therapeutics has become a shopping opportunity for two cash-rich drugmakers, Eli Lilly and PTC Therapeutics, who have emerged as winning bidders in a highly competitive court-supervised auction.
Open in Who Shared Issue with article?

Trump Orders Overhaul Of Childhood Vaccination Schedule, Calls For MMR Split

|
By Manas Mishra Verified
| The Pink Sheet Verified
A sweeping Trump executive order would shrink the routine childhood vaccine schedule to 11 diseases and break up the MMR shot – changes no monovalent US-licensed vaccine currently exists to deliver. US President Donald Trump has signed an executive order to replace the combined measles, mumps and rubella vaccine with three separate shots, and to limit routine childhood immunization recommendations to 11 diseases, down from 18, in a sweeping overhaul of the country’s vaccination schedule.
Open in Who Shared Issue with article?

Moderna’s Flu Vaccine Approval Brings Postmarket Studies, Uncertain Fall Sales Season

|
By Manas Mishra Verified
| The Pink Sheet Verified
Moderna must confirm its efficacy in patients 65 and older for the first mRNA influenza shot licensed in the US, but pediatric studies were deferred until data is obtained in patients 18 and older and with ACIP in limbo, though, the bigger challenge is reimbursement for the upcoming season. After a February refusal to file letter, the FDA approved Moderna’s flu vaccine.
Open in Who Shared Issue with article?
See all 5,217 licensed articles (6,179 Total)